Brief: Cumberland Posts Q1 Adjusted EPS Of $0.01
20/05/2020 21:23
May 20 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS FIRST QUARTER 2020
FINANCIAL
RESULTS & COMPANY UPDATE
* Q1 ADJUSTED EARNINGS PER SHARE $0.01
* Q1 REVENUE $8.3 MILLION
* Q1 LOSS PER SHARE $0.07
Source text for Eikon: ID:nPn7xvTNZa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM